These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12523258)

  • 21. Measure for measure--sugar or fats? Reconciling cardiovascular and diabetes risk with niacin therapy.
    Rosenson RS
    Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):72-3. PubMed ID: 17237831
    [No Abstract]   [Full Text] [Related]  

  • 22. Obesity and metabolic disease.
    Koopman RJ; Swofford SJ; Beard MN; Meadows SE
    Prim Care; 2009 Jun; 36(2):257-70. PubMed ID: 19501242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular risk in the spectrum of type 2 diabetes mellitus.
    Ahmed I; Goldstein BJ
    Mt Sinai J Med; 2006 Sep; 73(5):759-68. PubMed ID: 17008936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. American College of Endocrinology position statement on the insulin resistance syndrome.
    Einhorn D; Reaven GM; Cobin RH; Ford E; Ganda OP; Handelsman Y; Hellman R; Jellinger PS; Kendall D; Krauss RM; Neufeld ND; Petak SM; Rodbard HW; Seibel JA; Smith DA; Wilson PW
    Endocr Pract; 2003; 9(3):237-52. PubMed ID: 12924350
    [No Abstract]   [Full Text] [Related]  

  • 25. Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease.
    Schindhelm RK; Diamant M; Dekker JM; Tushuizen ME; Teerlink T; Heine RJ
    Diabetes Metab Res Rev; 2006; 22(6):437-43. PubMed ID: 16832839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Macrovascular complications of metabolic syndrome: an early intervention is imperative.
    Tenenbaum A; Motro M; Schwammenthal E; Fisman EZ
    Int J Cardiol; 2004 Nov; 97(2):167-72. PubMed ID: 15458679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The metabolic syndrome--early action to decrease risks for cardiovascular disease.
    Fritschi C; Richlin D
    AAOHN J; 2004 Aug; 52(8):320-2. PubMed ID: 15357369
    [No Abstract]   [Full Text] [Related]  

  • 28. Why metabolic syndrome criteria have not made prime time: a view from the clinic.
    Sattar N
    Int J Obes (Lond); 2008 May; 32 Suppl 2():S30-4. PubMed ID: 18469837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gout and the risk of type 2 diabetes among men with a high cardiovascular risk profile.
    Choi HK; De Vera MA; Krishnan E
    Rheumatology (Oxford); 2008 Oct; 47(10):1567-70. PubMed ID: 18710901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pancreatic renin-angiotensin-aldosterone system in the cardiometabolic syndrome and type 2 diabetes mellitus.
    Hayden MR; Sowers JR
    J Cardiometab Syndr; 2008; 3(3):129-31. PubMed ID: 18983326
    [No Abstract]   [Full Text] [Related]  

  • 31. How to best define the metabolic syndrome.
    Magliano DJ; Shaw JE; Zimmet PZ
    Ann Med; 2006; 38(1):34-41. PubMed ID: 16448987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease.
    Haffner SM
    Am J Cardiol; 2006 Jan; 97(2A):3A-11A. PubMed ID: 16442931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. From hyperglycemia to the risk of cardiovascular disease.
    Leiter LA
    Rev Cardiovasc Med; 2006; 7 Suppl 2():S3-9. PubMed ID: 17224875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin resistance syndrome in children.
    Scott LK
    Pediatr Nurs; 2006; 32(2):119-24, 143. PubMed ID: 16719421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic syndrome: what's in a name?
    Wubben DP; Adams AK
    WMJ; 2006 Jul; 105(5):17-20. PubMed ID: 16933408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The concept of cardiometabolic risk: Bridging the fields of diabetology and cardiology.
    Després JP; Cartier A; Côté M; Arsenault BJ
    Ann Med; 2008; 40(7):514-23. PubMed ID: 18608131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fenofibrate for cardiovascular disease prevention in metabolic syndrome and type 2 diabetes mellitus.
    Steiner G
    Am J Cardiol; 2008 Dec; 102(12A):28L-33L. PubMed ID: 19084087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of the metabolic syndrome.
    Grant RW; Meigs JB
    Panminerva Med; 2005 Dec; 47(4):219-28. PubMed ID: 16489321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What is metabolic syndrome, and how can it affect my heart health?
    Duke Med Health News; 2010 Oct; 16(10):8. PubMed ID: 21105224
    [No Abstract]   [Full Text] [Related]  

  • 40. The metabolic syndrome in children and adolescents.
    Zimmet P; Alberti G; Kaufman F; Tajima N; Silink M; Arslanian S; Wong G; Bennett P; Shaw J; Caprio S;
    Lancet; 2007 Jun; 369(9579):2059-61. PubMed ID: 17586288
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.